1. Home
  2. ADPT vs AMSC Comparison

ADPT vs AMSC Comparison

Compare ADPT & AMSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • AMSC
  • Stock Information
  • Founded
  • ADPT 2009
  • AMSC 1987
  • Country
  • ADPT United States
  • AMSC United States
  • Employees
  • ADPT N/A
  • AMSC N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • AMSC Metal Fabrications
  • Sector
  • ADPT Health Care
  • AMSC Consumer Discretionary
  • Exchange
  • ADPT Nasdaq
  • AMSC Nasdaq
  • Market Cap
  • ADPT 1.4B
  • AMSC 1.1B
  • IPO Year
  • ADPT 2019
  • AMSC 1991
  • Fundamental
  • Price
  • ADPT $11.48
  • AMSC $39.19
  • Analyst Decision
  • ADPT Strong Buy
  • AMSC Strong Buy
  • Analyst Count
  • ADPT 7
  • AMSC 3
  • Target Price
  • ADPT $10.57
  • AMSC $33.67
  • AVG Volume (30 Days)
  • ADPT 2.2M
  • AMSC 1.5M
  • Earning Date
  • ADPT 07-31-2025
  • AMSC 08-05-2025
  • Dividend Yield
  • ADPT N/A
  • AMSC N/A
  • EPS Growth
  • ADPT N/A
  • AMSC N/A
  • EPS
  • ADPT N/A
  • AMSC 0.16
  • Revenue
  • ADPT $189,527,000.00
  • AMSC $222,818,000.00
  • Revenue This Year
  • ADPT $24.46
  • AMSC $20.26
  • Revenue Next Year
  • ADPT $20.25
  • AMSC $12.73
  • P/E Ratio
  • ADPT N/A
  • AMSC $244.94
  • Revenue Growth
  • ADPT 8.61
  • AMSC 52.99
  • 52 Week Low
  • ADPT $3.30
  • AMSC $13.98
  • 52 Week High
  • ADPT $12.43
  • AMSC $39.70
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 63.39
  • AMSC 77.37
  • Support Level
  • ADPT $11.17
  • AMSC $34.87
  • Resistance Level
  • ADPT $12.43
  • AMSC $37.89
  • Average True Range (ATR)
  • ADPT 0.59
  • AMSC 2.03
  • MACD
  • ADPT 0.03
  • AMSC 0.42
  • Stochastic Oscillator
  • ADPT 62.45
  • AMSC 95.61

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About AMSC American Superconductor Corporation

American Superconductor Corp generates the ideas, technologies, and solutions that meet the world's demand for smarter, cleaner, and energy. Through its Windtec Solutions, the company enables manufacturers to launch wind turbines quickly, effectively, and profitably. Through its Gridtec Solutions, the company provides engineering planning services and grid systems that optimize network reliability, efficiency, and performance. The company's segment includes Grid and Wind. It generates maximum revenue from the Grid segment.

Share on Social Networks: